Cardio Week 3 Flashcards
what is atherosclerosis
progressive disease characterised by build up of plaque
what is the normal level for triglycerides
2.3mmol/l
what is the role of HDL
protective effect for risk of atherosclerosis and CHD
what are markers of high cholesterol
xanthelasma (xanthomas of eyelids), tendon xanthomas, tuberous xanthomas or eruptive xanthomas (small reddish-yellow pauples)
what is the events leading up to the formation of a fatty streak or plaque
damage - productive of adhesion molecules - attachment of monocytes and T cells - migration to sub endothelial space - macrophages take up oxidised LDL - forms lipid rich foam cells
what diseases are attributable to hypertension
aortic aneurysm, HR, LVH, MI, CHD, cerebral haemorrhage, preeclampsia, stroke, chronic kidney disease, blindness
what is the risk factors for CVD that most hypertensives have
dyslipidemia, diabetes, age, male gender, smoking, family history
what lifestyle modifications can be made to reduce risk of CVD
lose weight, limit alcohol intake, increase physical activity, reduce salt intake, stop smoking, limit intake of foods rich in fat and cholesterol
what is hypertension a risk factor for
cerebral haemorrhage, atheroma, renal failure, sudden cardiac death
what is primary hypertension
90% of cases, no obvious cause, increase in dietary salt leads to increase in BP
what is secondary hypertension
underlying disease implicated
what are common causes of secondary hypertension
renal disease (salt and water overload), sleep apnoea, aldosteronism, Reno-vascular disease
what are uncommon causes of secondary hypertension
cushings (excess corticosteroids), pheochromocytoma (excess noradrenaline) hyperparathyroidism, aortic coarctation (congenital narrowing)
what is benign hypertension
life threatening, asymptomatic, incidental finding, eventually causes LVH, congestive cardiac failure, increases atheroma, aneurysm rupture and renal disease
what is the process behind left ventricular hypertrophy
increased LV load - poor perfusion - interstitial fibrosis - micro infarcts - diastolic dysfunction results in cardiac death or failure
what is the cause of hypertensive atherosclerosis
blood vessel wall changes (esp in retina and kidney), thickening of media and hyaline arteriosclerosis where plasma proteins forced into vessel wall
what is malignant hypertension
serous, diastolic >130, can develop from either benign primary or secondary hypertension or arise de-novo - urgent treatment needed
causes of malignant hypertension
cerebral oedema (seen as papillodema), acute renal failure, acute heart failure, headache and cerebral haemorrhage
what is the consequence of pregnancy associated hypertension and proteinuria
pre-eclampsia - obstetric emergency and the hypertension is secondary to silent renal or systemic disease
what is the virchows triad that leads to thrombosis
endothelial injury, turbulent blood flow, hypercoaguable blood
what causes endothelial injury
hypertension, autoimmune disease (eg primary vasculitis)
thrombus via intravascular coagulation is caused by what two things
platelet activation and fibrin production via coagulation cascade
what is special about activated platelets
more sticky, attract and aggregate with other platelets, aggregate with fibrin (fibrin is end point of coagulation cascade)
what happens when endothelial damage occurs and endothelium is lost
collagen exposed, binds to Ia/IIb on platelets as does vWF, there is increase in platelet integrins, IIb/IIIa binds fibrogen and activated platelets release granules to attract other platelets (vWF, platelet activating factor PAD, TXA2 and ADP)
what is the common intrinsic pathway
XII-XII-IV-VIII
what is common extrinsic pathway
tissue factor joins factor VII
what is the complications of atherosclerosis
thrombosis, narrowed coronary artery (may be asymptomatic if myocardial O2 demand met), exercised induced angina (stable) or plaque rupture (unstable angina)
what is homeostasis
constant clotting and constant clot lysis
what are anti clotting proteins
protein C and S (degrades factor V and VIII) and antithrombin III (degrades II, IX and X)
what is the primary causes of hypercoaguability
Factor V lieden (mutation at point in factor V targeted by protein C and S: results in C, S and antithrombin III deficiency)
what secondary causes of hypercoaguability
prolonged immobility, significant tissue injury, autoimmune, MI, AF, cancer (activate coagulation cascade through tumour produced TF) and many cancer therapies injure endothelium
what are low risk secondary causes of hypercoagubility
the pill, smoking, renal disease (nephrotic syndrome) and cardiomyopathy
what happens to organs which are distal to branching arteries
more susceptible to embolism and infarction eg stroke and small bowel infection
what do you need to ensure when using ABPM (ambulatory BP monitoring) to confirm diagnosis
at least two measurements per hour during the persons usual waking hours
what do you need to ensure when using HBPM (home blood pressure monitoring) to confirm diagnosis
two consecutive seated measurements, 1 minute apart, BP recorded twice a day for at least 4 days - measurements on first day are discarded
what is stage 1 hypertension
140/90 or higher
what is stage 2 hypertension
160/100 or higher
what is severe hypertension
180/110 or higher
how can CV risk and organ damage be assessed
urine (protein), blood (glucose, electrolytes, creatine, estimated glomerular filtration rate and cholesterol) fundi (hypertensive retinopathy) and arrange 12 lead ECG
what is the care pathway for stage 1 hypertension
if organ damage present or high risk - hypertensive drugsif <40 yrs - consider specialist referral offer lifestyle interventions
what is care pathway for stage 2 hypertension
offer anti-hypertensive drug treatment
what information is given in patient education and adherence
provide info about benefits of drugs and side effects, details of patient organisation and annual review of care
first line treatment for aged under 55 years
ACE inhibitor or low cost angiotensin II receptor blocker ARB
first line treatment for over 55 years or black person of african or caribbean family origin of any age
calcium channel blocker
second line treatment for all
ace inhibitor/arb and calcium channel blocker
third line treatment for all
ACE/ARB and CCB and thiazide like diuretic
what is the treatment for resistant hypertension
ACE/ARB and CCB and thiazide like diuretic and consider further diuretic or alpha or beta blocker